Jomed’s Tacrolimus-Eluting Stent Endangered By Clinical Data, Funding
This article was originally published in The Gray Sheet
Executive Summary
Jomed will remove the ceramic coating used on the company's tacrolimus-eluting stent because of high restenosis rates in six-month follow-up study data